Ceritinib, Free Base

Hazard statements (CLP)

H302+H312+H332

Code

Statements

H302+H312+H332

Harmful if swallowed, in contact with skin or if inhaled

Hazard statements

pharmaceutically active substance that has not been fully tested May be harmful if swallowed, inhaled, or absorbed through the skin Ingestion may result in elevated liver enzymes (ALT/AST), nausea, diarrhea, anorexia (loss of appetite), vomiting, convulsion, pneumonia, interstitial lung disease/pneumonitis, respiratory failure, pneumothorax, dyspnea (shortness of breath), dehydration, hyperglycemia (high blood sugar), gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, prolonged QT interval (heart rhythm disorder), bradycardia (reduced heart rate), neuropathy comprised of paresthesia (sensation of tingling, tickling, prickling, pricking, or burning), asthenia (lack of muscle strength), gait disturbance, peripheral neuropathy, hypoesthesia (reduced sense of touch or sensation), dysesthesia (abnormal sense of touch), peripheral sensory neuropathy, neuralgia, peripheral motor neuropathy, hypotonia (decreased muscle tone), or polyneuropathy, and vision disorder comprised of vision impairment, blurred vision, photopsia (perception of flashing lights), accommodation disorder (inability of the eye to automatically change focus from distance to near objects), presbyopia (diminished ability to focus on near objects), or reduced visual acuity Exposure may cause irritation of the skin, eyes, mucous membranes, and upper respiratory tract H302+312+332 - Harmful if swallowed, in contact with skin or if inhaled

Precautionary statements

P2562 - Do not get in eyes, on skin or on clothing WARNING For Laboratory Research Use Only